- Home
- DPRO vs SGHT Comparison
DPRO vs SGHT Comparison
Compare DPRO & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DPRO
- SGHT
- Stock Information
- Founded
- DPRO 1998
- SGHT 2011
- Country
- DPRO Canada
- SGHT United States
- Employees
- DPRO N/A
- SGHT N/A
- Industry
- DPRO Aerospace
- SGHT Medical Specialities
- Sector
- DPRO Industrials
- SGHT Health Care
- Exchange
- DPRO Nasdaq
- SGHT Nasdaq
- Market Cap
- DPRO 175.1M
- SGHT 193.2M
- IPO Year
- DPRO N/A
- SGHT 2021
- Fundamental
- Price
- DPRO $8.95
- SGHT $4.92
- Analyst Decision
- DPRO Strong Buy
- SGHT Buy
- Analyst Count
- DPRO 1
- SGHT 8
- Target Price
- DPRO $14.00
- SGHT $4.50
- AVG Volume (30 Days)
- DPRO 5.9M
- SGHT 222.6K
- Earning Date
- DPRO 11-13-2025
- SGHT 11-06-2025
- Dividend Yield
- DPRO N/A
- SGHT N/A
- EPS Growth
- DPRO N/A
- SGHT N/A
- EPS
- DPRO N/A
- SGHT N/A
- Revenue
- DPRO $5,250,872.00
- SGHT $76,303,000.00
- Revenue This Year
- DPRO $41.59
- SGHT N/A
- Revenue Next Year
- DPRO $137.37
- SGHT $12.04
- P/E Ratio
- DPRO N/A
- SGHT N/A
- Revenue Growth
- DPRO 17.08
- SGHT N/A
- 52 Week Low
- DPRO $1.63
- SGHT $2.03
- 52 Week High
- DPRO $14.40
- SGHT $5.48
- Technical
- Relative Strength Index (RSI)
- DPRO 51.51
- SGHT 66.19
- Support Level
- DPRO $8.31
- SGHT $4.87
- Resistance Level
- DPRO $10.19
- SGHT $5.25
- Average True Range (ATR)
- DPRO 1.20
- SGHT 0.32
- MACD
- DPRO -0.35
- SGHT 0.10
- Stochastic Oscillator
- DPRO 25.68
- SGHT 81.50
About DPRO Draganfly Inc.
Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.